| Product Code: ETC12572626 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Japan's import shipments of lopinavir were primarily sourced from the USA, Germany, Switzerland, Ireland, and Sweden. The market exhibited a very low concentration in terms of HHI, indicating a diverse import landscape. Despite a negative CAGR of -3.67% from 2020 to 2024, the growth rate improved slightly to -3.17% in 2024. This suggests a relatively stable market for lopinavir imports in Japan, with key suppliers maintaining their positions and contributing to the overall supply chain.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Lopinavir Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Lopinavir Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Lopinavir Market - Industry Life Cycle |
3.4 Japan Lopinavir Market - Porter's Five Forces |
3.5 Japan Lopinavir Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Lopinavir Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.7 Japan Lopinavir Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Japan Lopinavir Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Japan Lopinavir Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Japan Lopinavir Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 High prevalence of HIV/AIDS in Japan |
4.2.2 Increasing awareness about antiretroviral therapy |
4.2.3 Government initiatives to improve healthcare infrastructure |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 Competition from other antiretroviral drugs |
4.3.3 High cost of lopinavir treatment |
5 Japan Lopinavir Market Trends |
6 Japan Lopinavir Market, By Types |
6.1 Japan Lopinavir Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Lopinavir Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Japan Lopinavir Market Revenues & Volume, By Antiretroviral, 2021 - 2031F |
6.1.4 Japan Lopinavir Market Revenues & Volume, By Protease Inhibitor (Anti-HIV), 2021 - 2031F |
6.2 Japan Lopinavir Market, By Dosage |
6.2.1 Overview and Analysis |
6.2.2 Japan Lopinavir Market Revenues & Volume, By Tablet, 2021 - 2031F |
6.2.3 Japan Lopinavir Market Revenues & Volume, By Capsule, 2021 - 2031F |
6.2.4 Japan Lopinavir Market Revenues & Volume, By Oral solution, 2021 - 2031F |
6.3 Japan Lopinavir Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Japan Lopinavir Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Japan Lopinavir Market Revenues & Volume, By Other, 2021 - 2031F |
6.4 Japan Lopinavir Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Japan Lopinavir Market Revenues & Volume, By Human Immunodeficiency Virus-1 (HIV-1), 2021 - 2031F |
6.4.3 Japan Lopinavir Market Revenues & Volume, By Others, 2021 - 2031F |
6.5 Japan Lopinavir Market, By End user |
6.5.1 Overview and Analysis |
6.5.2 Japan Lopinavir Market Revenues & Volume, By Clinic, 2021 - 2031F |
6.5.3 Japan Lopinavir Market Revenues & Volume, By Hospital, 2021 - 2031F |
6.5.4 Japan Lopinavir Market Revenues & Volume, By Others, 2021 - 2031F |
7 Japan Lopinavir Market Import-Export Trade Statistics |
7.1 Japan Lopinavir Market Export to Major Countries |
7.2 Japan Lopinavir Market Imports from Major Countries |
8 Japan Lopinavir Market Key Performance Indicators |
8.1 Number of new HIV/AIDS cases diagnosed annually |
8.2 Adoption rate of lopinavir in HIV/AIDS treatment protocols |
8.3 Patient adherence rate to lopinavir treatment |
8.4 Research and development investment in improving lopinavir formulations |
8.5 Number of healthcare facilities offering lopinavir treatment |
9 Japan Lopinavir Market - Opportunity Assessment |
9.1 Japan Lopinavir Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Lopinavir Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.3 Japan Lopinavir Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Japan Lopinavir Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Japan Lopinavir Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Japan Lopinavir Market - Competitive Landscape |
10.1 Japan Lopinavir Market Revenue Share, By Companies, 2024 |
10.2 Japan Lopinavir Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here